Work

The Role of the VEGF Family in Atherosclerosis Development and Its Potential as Treatment Targets

Year: 2022

Type: review

Abstract: The vascular endothelial growth factor (VEGF) family, the crucial regulator of angiogenesis, lymphangiogenesis, lipid metabolism and inflammation, is involved in the development of atherosclerosis and further CVDs (cardiovascular diseases). This review discusses the general regulation and functions of VEGFs, their role in lipid metabolism and atherosclerosis development and progression. These functions present the great potential of applying the VEGF family as a target in the treatment of atherosclerosis and related CVDs. In addition, we discuss several modern anti-atherosclerosis VEGFs-targeted experimental procedures, drugs and natural compounds, which could significantly improve the efficiency of atherosclerosis and related CVDs' treatment.

Source: International Journal of Molecular Sciences

DOI: 10.3390/ijms23020931

Authors: Siarhei A. Dabravolski, Victoria A. Khotina, Andrey V. Omelchenko, Vladislav A. Kalmykov, Alexander N. Orekhov

Institutions: Vitebsk State Academy of Veterinary Medicine, Research Institute of General Pathology and Pathophysiology, the Russian Academy of Medical Sciences, Research Institute of Human Morphology, Institute for Atherosclerosis Research

Language: English

Topic: Atherosclerosis and Cardiovascular Diseases

Subfield: Immunology

Field: Immunology and Microbiology

Domain: Life Sciences

SDG: Good health and well-being

Open Access status: gold

Estimated APC paid: $2,408